Martin R. Farlow

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

Samantha Rogers, Martin R. Farlow, Rachelle S. Doody et al. · Neurology · 1998 · 1.6K citations

Neuropsychology, Placebo-controlled Trial, Pharmacotherapy +20

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

Maria Grazia Spillantini, Jill R. Murrell, Michel Goedert et al. · Proceedings of the National Academy of Sciences · 1998 · 1.5K citations · Full text

Abnormal Tau Filaments, Genetics, Molecular Biology +18

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

Pierre N. Tariot, Martin R. Farlow, George T. Grossberg et al. · JAMA · 2004 · 1.4K citations

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations